Zacks Investment Management Abbott Laboratories Transaction History

Zacks Investment Management

$11.4 Billion
Q3 2024

A detailed history of Zacks Investment Management transactions in Abbott Laboratories stock. As of the latest transaction made, Zacks Investment Management holds 600,676 shares of ABT stock, worth $68.9 Million. This represents 0.6% of its overall portfolio holdings.

Number of Shares

600,676

Holding current value

$68.9 Million

% of portfolio

0.6%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$100.07 - $118.13 $60.1 Million - $71 Million	600,676 New	600,676 $68.5 Million
Q1 2024 May 15, 2024	BUY	$109.52 - $120.96 $3.48 Million - $3.84 Million	31,734 Added 6.62%	510,776 $58.1 Million
Q4 2023 Feb 14, 2024	SELL	$90.19 - $110.4 $1.96 Million - $2.4 Million	-21,773 Reduced 4.35%	479,042 $52.7 Million
Q3 2023 Nov 14, 2023	BUY	$95.53 - $114.62 $4.97 Million - $5.96 Million	51,991 Added 11.58%	500,815 $48.5 Million
Q2 2023 Aug 15, 2023	BUY	$100.78 - $112.29 $3.84 Million - $4.28 Million	38,115 Added 9.28%	448,824 $48.9 Million
Q2 2023 Aug 14, 2023	BUY	$100.78 - $112.29 $1.23 Million - $1.37 Million	12,188 Added 3.06%	410,709 $44.8 Million
Q1 2023 May 15, 2023	BUY	$96.86 - $114.01 $1.99 Million - $2.34 Million	20,554 Added 5.44%	398,521 $40.4 Million
Q4 2022 Feb 14, 2023	SELL	$95.06 - $111.52 $4.67 Million - $5.48 Million	-49,114 Reduced 11.5%	377,967 $41.5 Million
Q3 2022 Nov 14, 2022	BUY	$96.76 - $112.03 $35.1 Million - $40.6 Million	362,672 Added 563.08%	427,081 $41.3 Million
Q2 2022 Aug 15, 2022	SELL	$102.07 - $123.37 $11,533 - $13,940	-113 Reduced 0.18%	64,409 $7 Million
Q1 2022 May 13, 2022	BUY	$114.02 - $139.04 $6.51 Million - $7.94 Million	57,128 Added 772.63%	64,522 $7.64 Million
Q4 2021 Feb 15, 2022	SELL	$115.53 - $141.46 $134,707 - $164,942	-1,166 Reduced 13.62%	7,394 $1.04 Million
Q3 2021 Nov 15, 2021	BUY	$116.66 - $129.06 $190,272 - $210,496	1,631 Added 23.54%	8,560 $1.01 Million
Q2 2021 Aug 16, 2021	SELL	$105.79 - $124.53 $4.15 Million - $4.88 Million	-39,221 Reduced 84.99%	6,929 $803,000
Q1 2021 May 17, 2021	BUY	$108.84 - $128.23 $728,792 - $858,628	6,696 Added 16.97%	46,150 $5.53 Million
Q4 2020 Feb 16, 2021	BUY	$105.0 - $114.42 $2.08 Million - $2.27 Million	19,797 Added 100.71%	39,454 $4.32 Million
Q3 2020 Nov 16, 2020	SELL	$91.64 - $111.29 $990,811 - $1.2 Million	-10,812 Reduced 35.49%	19,657 $2.14 Million
Q2 2020 Aug 14, 2020	BUY	$76.57 - $98.0 $1.42 Million - $1.82 Million	18,556 Added 155.76%	30,469 $2.79 Million
Q1 2020 May 15, 2020	SELL	$62.82 - $91.86 $72,494 - $106,006	-1,154 Reduced 8.83%	11,913 $940,000
Q4 2019 Feb 14, 2020	BUY	$78.51 - $87.4 $75,762 - $84,341	965 Added 7.97%	13,067 $1.14 Million
Q3 2019 Nov 14, 2019	SELL	$81.84 - $88.74 $19,477 - $21,120	-238 Reduced 1.93%	12,102 $1.01 Million
Q2 2019 Aug 14, 2019	BUY	$72.88 - $85.0 $899,339 - $1.05 Million	12,340 New	12,340 $1.04 Million

Others Institutions Holding ABT

# of Institutions

3,186

Shares Held

1.3B

Call Options Held

8.74M

Put Options Held

8.08M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $201B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Zacks Investment Management, based on Form 13F filings with the SEC.

News

Stay updated on Zacks Investment Management with notifications on news.

Account

Zacks Investment Management Abbott Laboratories Transaction History